Abstract

BackgroundIn response to the coronavirus disease (COVID‐19) outbreak that unfolded across Europe in 2020, the World Health Organisation (WHO) called for repurposing existing influenza surveillance systems to monitor COVID‐19. This analysis aimed to compare descriptively the extent to which influenza surveillance systems were adapted and enhanced and how COVID‐19 surveillance could ultimately benefit or disrupt routine influenza surveillance.MethodsWe used a previously developed framework in France, Germany, Italy, Spain and the United Kingdom to describe COVID‐19 surveillance and its impact on influenza surveillance. The framework divides surveillance systems into seven subsystems and 20 comparable outcomes of interest and uses five evaluation criteria based on WHO guidance. Information on influenza and COVID‐19 surveillance systems were collected from publicly available resources shared by European and national public health agencies.ResultsOverall, non‐medically attended, virological, primary care and mortality surveillance were adapted in most countries to monitor COVID‐19, although community, outbreak and hospital surveillance were reinforced in all countries. Data granularity improved, with more detailed demographic and medical information recorded. A shift to systematic notification for cases and deaths enhanced both geographic and population representativeness, although the sampling strategy benefited from the roll out of widespread molecular testing. Data communication was greatly enhanced, contributing to improved public awareness.ConclusionsWell‐established influenza surveillance systems are a key component of pandemic preparedness, and their upgrade allowed European countries to respond to the COVID‐19 pandemic. However, uncertainties remain on how both influenza and COVID‐19 surveillance can be jointly and durably implemented.

Highlights

  • The first cases of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), were reported in Europe in January 2020.1 On 11 March 2020, the World Health Organisation (WHO) identified COVID-19 as a pandemic.[2]

  • Well-established influenza surveillance systems are a key component of pandemic preparedness, and their upgrade allowed European countries to respond to the COVID-19 pandemic

  • Information to describe influenza and COVID-19 surveillance systems were extracted from publicly available sources during the first wave in Europe, using online European Centre for Disease Prevention and Control (ECDC) and WHO resources followed by national public health resources in each country, in particular: Santé publique (SpF) (France), Robert Koch Institute (RKI) (Germany), Istituto Superiore di Sanità (ISS) (Italy), Instituto de Salud Carlos III (ISCIII) (Spain) and Public Health England (PHE)/Public Health Wales/Public Health Scotland/Public Health Northern Ireland (UK).[14,15,16,17,18,19,20,21,22,23,24,25,26,27,28]

Read more

Summary

| INTRODUCTION

The first cases of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), were reported in Europe in January 2020.1 On 11 March 2020, the World Health Organisation (WHO) identified COVID-19 as a pandemic.[2]. Influenza surveillance systems are well established in Europe, reflecting the WHO Global Influenza Surveillance and Response System requirements[7] and supplemented by national tools or pan-European initiatives such as InfluenzaNet for non-medically attended participatory syndromic surveillance systems[8] and EuroMOMO for excess mortality modelling.[9] the objectives of routine seasonal influenza surveillance and COVID-19 surveillance are not exactly the same. For both influenza and COVID-19, surveillance enables an understanding of the epidemiology, virology and geographic spread of disease and measuring of disease burden, severity and impact of prevention measures. The purpose of this research was to understand to what extent influenza surveillance systems in five western European countries were repurposed, strengthened or complemented by new components for COVID-19 surveillance and the implications for future influenza surveillance

| METHODS
Associated excess deaths
| RESULTS
Findings
| CONCLUSIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.